Vivimed Labs Ltd. - Research Center
532660 VIVIMEDLAB Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 16.58 | 16.58 | 16.58 | 16.51 | 16.51 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 402.69 | 469.89 | 499.31 | 518.12 | 512.90 |
| Loan funds | |||||
| Secured loans | 356.94 | 250.80 | 255.34 | 248.52 | 325.36 |
| Unsecured loans | - | - | - | 55.32 | 49.30 |
| Total | 776.22 | 737.27 | 771.23 | 838.46 | 904.07 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 535.17 | 507.67 | 434.38 | 451.32 | 460.31 |
| Less : revaluation reserve | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 |
| Less : accumulated depreciation | 106.37 | 91.17 | 77.96 | 70.62 | 55.48 |
| Net block | 390.81 | 378.50 | 318.42 | 342.70 | 366.83 |
| Capital work-in-progress | 40.03 | 58.45 | 69.77 | 64.18 | 42.78 |
| Investments | 161.14 | 161.14 | 87.50 | 87.53 | 151.87 |
| Net current assets | |||||
| Current assets, loans & advances | 441.82 | 458.75 | 553.64 | 622.14 | 655.94 |
| Less : current liabilities & provisions | 257.57 | 319.57 | 258.09 | 278.10 | 313.34 |
| Total net current assets | 184.24 | 139.18 | 295.55 | 344.04 | 342.60 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 776.22 | 737.27 | 771.23 | 838.46 | 904.07 |
| Notes: | |||||
| Book value of unquoted investments | 161.14 | 161.14 | 87.50 | 87.53 | 151.87 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 215.57 | 220.66 | 11.54 | 55.52 | 160.87 |
| Number of equity sharesoutstanding (Lacs) | 829.14 | 829.14 | 829.14 | 825.24 | 825.24 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis